Efficacy and safety of TMC278 in antiretroviral-naive HIV-1 patients: week 96 results of a phase IIb randomized trial
暂无分享,去创建一个
K. Ruxrungtham | E. Katabira | D. Steyn | A. Pozniak | B. Grinsztejn | J. Morales-Ramirez | L. Rimsky | S. Vanveggel | K. Boven | S. Lupo | M. Santoscoy | Mario Santoscoy